Tower Research Capital (TRC)’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.5K | Sell |
|
|||||
|
2025
Q2 | $128K | Buy |
|
|||||
|
2025
Q1 | $37.9K | Buy |
|
|||||
|
2024
Q4 | $36.3K | Buy |
|
|||||
|
2024
Q3 | $9.51K | Sell |
|
|||||
|
2024
Q2 | $99.9K | Buy |
|
|||||
|
2024
Q1 | $3.79K | Sell |
|
|||||
|
2023
Q4 | $99K | Buy |
|
|||||
|
2023
Q3 | $52.7K | Buy |
|
|||||
|
2023
Q2 | $44.3K | Buy |
|
|||||
|
2023
Q1 | $35K | Sell |
|
|||||
|
2022
Q4 | $49K | Sell |
|
|||||
|
2022
Q3 | $82K | Sell |
|
|||||
|
2022
Q2 | $103K | Buy |
|
|||||
|
2022
Q1 | $63K | Sell |
|
|||||
|
2021
Q4 | $198K | Sell |
|
|||||
|
2021
Q3 | $218K | Buy |
|
|||||
|
2021
Q2 | $181K | Sell |
|
|||||
|
2021
Q1 | $301K | Buy |
|
|||||
|
2020
Q4 | $57K | Sell |
|
|||||
|
2020
Q3 | $259K | Buy |
|
|||||
|
2020
Q2 | $51K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2K | Sell |
|
|||||
|
2019
Q2 | $22K | Buy |
|
|||||
|
2019
Q1 | $10K | Sell |
|
|||||
|
2018
Q4 | $26K | Buy |
|
|||||
|
2018
Q3 | $36K | Buy |
|
|||||
|
2018
Q2 | $34K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $18K | Sell |
|
|||||
|
2017
Q3 | $74K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $20K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $5K | Sell |
|
|||||
|
2016
Q1 | $53K | Buy |
|
|||||
|
2015
Q4 | $5K | Buy |
|